Brief: Irlab Gets Waiver From EMA About Studies With Mesdopetam In Parkinson's Disease

IRLAB Therapeutics AB

23/01/2025 06:00

Jan 23 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB HAS RECEIVED A WAIVER FROM THE EMA REGARDING
PEDIATRIC
STUDIES WITH MESDOPETAM IN PARKINSON'S DISEASE

Source text:  ID:nMFNc3djf2 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))